Interestingly, through ROC and ULR analysis of four genes, we found that the combination of IFIT2, IFIT3, RSAD2, and PARP14 may potentially act as a novel biomarker for SSc-PAH. The gene discussed is IFIT2; the disease is pulmonary arterial hypertension.